Literature DB >> 27027248

Solution Structure and Constrained Molecular Dynamics Study of Vitamin B12 Conjugates of the Anorectic Peptide PYY(3-36).

Kelly E Henry1, Deborah J Kerwood1, Damian G Allis1, Jayme L Workinger1, Ron L Bonaccorso1, George G Holz2, Christian L Roth3, Jon Zubieta1, Robert P Doyle4,5.   

Abstract

Vitamin B12 -peptide conjugates have considerable therapeutic potential through improved pharmacokinetic and/or pharmacodynamic properties imparted on the peptide upon covalent attachment to vitamin B12 (B12 ). There remains a lack of structural studies investigating the effects of B12 conjugation on peptide secondary structure. Determining the solution structure of a B12 -peptide conjugate or conjugates and measuring functions of the conjugate(s) at the target peptide receptor may offer considerable insight concerning the future design of fully optimized conjugates. This methodology is especially useful in tandem with constrained molecular dynamics (MD) studies, such that predictions may be made about conjugates not yet synthesized. Focusing on two B12 conjugates of the anorectic peptide PYY(3-36), one of which was previously demonstrated to have improved food intake reduction compared with PYY(3-36), we performed NMR structural analyses and used the information to conduct MD simulations. The study provides rare structural insight into vitamin B12 conjugates and validates the fact that B12 can be conjugated to a peptide without markedly affecting peptide secondary structure.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  GPCR; NMR spectroscopy; PYY(3-36); molecular dynamics; vitamin B12

Mesh:

Substances:

Year:  2016        PMID: 27027248      PMCID: PMC4878914          DOI: 10.1002/cmdc.201600073

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  37 in total

1.  Solution structure of monomeric peptide YY supports the functional significance of the PP-fold.

Authors:  D A Keire; M Kobayashi; T E Solomon; J R Reeve
Journal:  Biochemistry       Date:  2000-08-15       Impact factor: 3.162

Review 2.  Recent trends in the development of vitamin B12 derivatives for medicinal applications.

Authors:  Felix Zelder
Journal:  Chem Commun (Camb)       Date:  2015-08-19       Impact factor: 6.222

Review 3.  Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide.

Authors:  D Larhammar
Journal:  Regul Pept       Date:  1996-04-09

4.  Re-evaluation of receptor-ligand interactions of the human neuropeptide Y receptor Y1: a site-directed mutagenesis study.

Authors:  Paula Sjödin; Sara K S Holmberg; Helena Akerberg; Magnus M Berglund; Nina Mohell; Dan Larhammar
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

5.  Peptide hormone isoforms: N-terminally branched PYY3-36 isoforms give improved lipid and fat-cell metabolism in diet-induced obese mice.

Authors:  Søren L Pedersen; Pottayil G Sasikumar; Shekar Chelur; Birgitte Holst; Andreas Artmann; Knud J Jensen; Niels Vrang
Journal:  J Pept Sci       Date:  2010-11       Impact factor: 1.905

6.  Synthesis, characterization and pharmacodynamics of vitamin-B(12)-conjugated glucagon-like peptide-1.

Authors:  Susan Clardy-James; Oleg G Chepurny; Colin A Leech; George G Holz; Robert P Doyle
Journal:  ChemMedChem       Date:  2012-11-30       Impact factor: 3.466

7.  Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36.

Authors:  D Grandt; M Schimiczek; C Beglinger; P Layer; H Goebell; V E Eysselein; J R Reeve
Journal:  Regul Pept       Date:  1994-05-05

8.  Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV.

Authors:  R Mentlein; P Dahms; D Grandt; R Krüger
Journal:  Regul Pept       Date:  1993-12-10

9.  PYY(3-36) induces Fos in the arcuate nucleus and in both catecholaminergic and non-catecholaminergic neurons in the nucleus tractus solitarius of rats.

Authors:  J E Blevins; P K Chelikani; A C Haver; R D Reidelberger
Journal:  Peptides       Date:  2007-11-17       Impact factor: 3.750

10.  Neuropeptide Y receptors: how to get subtype selectivity.

Authors:  Xavier Pedragosa-Badia; Jan Stichel; Annette G Beck-Sickinger
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-04       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.